Success Metrics

Active Trials
0(0%)

Phase Distribution

Ph phase_4
1
50%
Ph not_applicable
1
50%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution2 total trials
Phase 4Post-market surveillance
1(50.0%)
N/ANon-phased studies
1(50.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

0.0%

0 of 1 finished

Non-Completion Rate

100.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

2

all time

Status Distribution
Active(1)
Terminated(1)

Detailed Status

Not yet recruiting1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
2
Active
0
Success Rate
N/A
Most Advanced
Phase 4

Trials by Phase

Phase 41 (50.0%)
N/A1 (50.0%)

Trials by Status

not_yet_recruiting150%
withdrawn150%

Recent Activity

0 active trials
Showing 2 of 2
not_yet_recruitingnot_applicable

Contingency Management to Improve Medication for Opioid Use Disorder Continuation After the Emergency Department

NCT07129902
withdrawnphase_4

Management of Hyperglycemia in the ER: A Randomized Clinical Trial of a Subcutaneous Insulin Aspart Protocol Coupled With Rapid Initiation of Basal Bolus Insulin Prior to Hospital Admission Versus Usual Care

NCT00663624

Clinical Trials (2)

Showing 2 of 2 trials
NCT07129902Not Applicable

Contingency Management to Improve Medication for Opioid Use Disorder Continuation After the Emergency Department

Not Yet Recruiting
NCT00663624Phase 4

Management of Hyperglycemia in the ER: A Randomized Clinical Trial of a Subcutaneous Insulin Aspart Protocol Coupled With Rapid Initiation of Basal Bolus Insulin Prior to Hospital Admission Versus Usual Care

Withdrawn

All 2 trials loaded

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
2